TeleHepC Treatment Trial

Completed · Not applicable

Conditions studied: Hepatitis C

In brief

The main goal of this study is to test the efficacy of a peer-facilitated telemedicine HCV treatment implementation strategy for people who use drugs versus local HCV treatment referral for achieving HCV sustained viral response at 12 weeks post-treatment (SVR12).

Key facts

Study ID

NCT04798521

Run by

Oregon Health and Science University

People needed

203

Starts

2020-06-30

Expected to finish

2024-01-10

Last updated by the study team

2024-10-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• live in the study area
• have injected drugs or report recreational opioid use without injection in the last 90 days
• are age 18 or greater
• have chronic active, untreated hepatitis C (defined as positive HCV RNA)
• are seeking treatment for hepatitis C infection.
• are able to communicate in English (this is due to the fact that less than 5% of the population in which we are targeting will be non-English speaking; see "Non-English Speaking Subjects" for additional information).
• are enrolled in health insurance

You may not qualify if…

• Have decompensated cirrhosis, defined as Child-Turcotte-Pugh (CTP) score of 7 or greater, or CTP B cirrhosis. CTP scoring is a composite of laboratory metrics (bilirubin, albumin, PT/INR) and clinical findings, including:
• increased abdominal or lower extremity swelling
• confusion consistent with hepatic encephalopathy
• Are pregnant or breastfeeding

Where it is running

• Central City Concern — Portland, Oregon, United States
• Comagine Health — Portland, Oregon, United States
• HIV Alliance — Roseburg, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.